Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Toxicol Lett. 2020 May 24;331:82–91. doi: 10.1016/j.toxlet.2020.05.023

Fig. 6.

Fig. 6

Effects of MG132 on methylmercury (MeHg)-induced acute cell injury in PC12 and BRL cells. Cells were pretreated with or without MG132 (1 μM for 24 h), followed by treatment with MeHg. A, B) Protein expression of HIF-1α and downstream targets glucose transporter-1 (GLUT-1), vascular endothelial growth factor-A (VEGF-A), and erythropoietin (EPO) was analyzed by western blotting. β-Actin served as the loading control. C) Cell viability was measured by MTT assay. *p < 0.05, compared with the control group; #p < 0.05, compared with the MeHg group. Control groups were treated with free media without any agents. Statistical analysis was performed by one-way analysis of variance followed by a Dunnett test, a multiple comparison procedure.